Personalized Medicine: being up-to-date August 24, 2007
Posted by Bertalan Meskó in Health, Health 2.0, Invention, Medicine, Medicine 2.0, Personalized medicine, Prevention, genetics, science.trackback
I’m in the middle of several projects now, so I just wanted to share a bunch of links with you about the recent improvements and news of personalized medicine. If you read these posts/articles/papers, you’re going to be totally up-to-date in this field.
- Personalized Medicine, Part 1: Coumadin (warfarin) and Part 2: Metabolic Activation of Codeine to Morphine: a must read.
…individual patients respond quite differently to the same dose of Coumadin. Two genetic markers have been identified… and the FDA has suggested that they be used to determine the minimal starting dose of Coumadin; patients with variations in these genetic markers may require a smaller dose of Coumadin than those with the normal, or “reference,” gene marker.
- Genetic Testing Cited for Blood Thinner (ABC News)
- Genomic Medicine Hits Mainstream Milestone (Wired Science)
Because it takes time to get test results, doctors typically have to decide the initial dose using older methods. Some testing labs say they can deliver results in one to three days.
- The FDA’s big personalized-medicine push (VentureBeat)
More generally, the implementation of pharmacogenomics in routine clinical practice presents significant challenges. This article presents specific clinical examples of such challenges and discusses how obstacles to implementation of pharmacogenomic testing can be addressed.
Follow Hsien, Steve, Blaine, Jason, Ogan and many other quality bloggers for more in the field of personalized medicine (of course, don’t miss Scienceroll either…).
Personalized medicine is the upcoming revolution that will change how how drugs are prescribed. Thanks for posting this. I was particularly interested personally in the article about two gene variations for patients taking Coumadin, as my mother is one of them.
You’re most welcome, Snowcrash! It’s my pleasure that it helped…
Hi Berci,
As always, I am learning a lot each time I come visit your blog. This is a great follow up article to the personalized medicine article I’ve read before. I am at this very moment attending BarCamp Houston (just check them out at BarCamp.org). It’s very technology oriented. I’ve chatted with some people about medical blogs and such especially the concept of 2.0 in medicine and how we learn about medicine. Which brought me to think progressive bloggers like you should be doing presentations here too. I’ve learned that BarCamp is done all over the world. It’s a very open environment, open learning, wonderfully geeky and I think Medicine & Medical bloggers should be exposed to this too. I will be blogging about my experience here in a few days. I just thought I’d mention it to you as I do follow your postings in Med 2.0 along with Victor Castilla’s and I want to thank you for all these as I’ve said I’m learning a lot!
All the best!
It’s always my pleasure when you like one of my articles.
Actually, I’ve already posted some presentations of mine here (scienceroll.com/medicine-20) and I’m going to present an other slideshow in Second Life on Monday 16:00 GMT on the island organized by Nature. If you have time, take a look at it as many other bloggers/ people interested in web 2.0 and medicine will be there.
And never mind the fact that I’m in an unlucky situation as I live far away from any other medical bloggers writing on this field. So I have to grab all of these opportunities (presentation, Second Life, blogs).
I’m looking forward to read your post about Barcamp!
And thank you for the kind words!
Berci
[...] Ethical considerations from an intriguingly personal standpoint are the subject of the description of the Personal Genome Project by GenomeBoy. Sandwalk believes that aside from the safety issue, there doesn’t seem to be any good reason to forbid the cloning of humans. Cancer Genetics considers genetic testing disclosure and when children should be told the results. Terra Sigillata discusses two announcements from the U.S. FDA on genetic issues in drug safety, concerning Coumadin (warfarin) and the metabolic activation of codeine to morphine. ScienceRoll also keeps us up-to-date on personalized medicine. [...]